Eric di Luccio
CTO, Executive Director, Head of R & d Department at Hirotsuバイオサイエンス
Based in Tokyo, Japan
7-day free trial · no credit card
Seniority
C-Team
Department
Engineering
Location
Tokyo
Industry
Hospitals and Health Care
Company size
13
Contact information
Reveal Eric's email and phone
Direct contact data is gated. Sign up and reveal. You only pay for verified records.
e•••••••@hbio.jp
Phone
5 credits+81 ••• •••• ••••
You only pay for valid records. Bounced emails and disconnected numbers cost nothing.
Background
About Eric di Luccio
Executive Director, Chief Technology Officer (CTO), Head of R&D at Hirotsu Bio Science Inc, Japan. HIROTSU BIO SCIENCE employs the world’s first biological diagnostic technology based on the olfaction of nematodes to offer a practical and high-sensitivity multi-cancer early detection test. Hirotsu Bio Science developed and launched the world’s first pancreatic cancer early detection test with high sensitivity and high specificity, noninvasive (based on urine). Successfully led the R&D of the world’s first pancreatic cancer early detection test with high sensitivity and specificity, noninvasive (based on urine). Business starts in late 2022. Comprehensive 22 years of scientific, biological, and medical experience from academia to the private sector: specialist in cancer biology, early cancer diagnosis, non-invasive cancer diagnosis, cancer epigenetics, and drug design. Experienced team leader in multiple countries and cultures (United States, South Korea, and Japan). Proven experience in driving projects forward from R&D to business start.
Decision-makers
Other people at Hirotsuバイオサイエンス
Build a list of verified contacts at Hirotsuバイオサイエンス
Free for 7 days · 50 credits · no card · only pay for verified records.
Reach more buyers like Eric
250M+ professionals with verified email and phone. You only pay for records that actually verify.
7-day trial · no credit card · cancel anytime